A Rakuten Company

More titles to consider

Shopping Cart

itemsitem

Synopsis

How can policy-makers ensure that we benefit from the health developments brought by genomics while satisfying both the expectations of society and the economic imperatives? This book offers a critique of the new governance agenda for science and innovation in the context of the life sciences, and particularly genomics. The authors argue that the governance of genomics presents policy-makers worldwide with a variety of new problems - their valuable research here offers the solutions.

People who read this also enjoyed

Get a 1 year subscription
for / issue

Read This On

You can read this item using any of the following Kobo apps and devices:

  • DESKTOP
  • eREADERS
  • TABLETS
  • IOS
  • ANDROID
  • BLACKBERRY
  • WINDOWS